Dongsheng Tu

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 34

Top Topics

Neuropathic Pain

Metastatic Colorectal Cancer

Top Venues

Statistics in medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

JMIR research protocols

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Joao Paulo Solar Vasconcelos, Nan Chen, Emma Titmuss, Dongsheng Tu, Stephanie Y Brule, Rachel Goodwin, Derek J Jonker, Timothy Jay Price, Zalcberg John, Malcolm J Moore, Christos S Karapetis, Lillian L Siu, Jeremy Shapiro, R John Simes, Sharlene Gill, Chris J O'Callaghan, Jonathan M Loree
Transverse colon primary tumor location as a biomarker in metastatic colorectal cancer: A pooled analysis of CCTG/AGITG CO.17 and CO.20 randomized clinical trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet E Feilotter, Hagen F Kennecke, Leylah Drusbosky, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Loree
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo- RAS -Wildtype Metastatic Colorectal Cancer Is Transient. JCO precision oncology 8 (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Rong Jiang, Yanling Feng, Yulian Chen, Xi Cheng, Ting Yan Shi, Wen Gao, Huixun Jia, Shiyang Jiang, Yi Guo, Xiao Huang, Dongsheng Tu, Yuqin Zhang, Huijuan Yang, Ping Zhang, Jihong Liu, Jianqing Zhu, Rong Yu Zang, null null
Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nature medicine 30 (8) (2024)
Rong Jiang, Yanling Feng, Yulian Chen, Xi Cheng, Ting Yan Shi, Wen Gao, Huixun Jia, Shiyang Jiang, Yi Guo, Xiao Huang, Dongsheng Tu, Yuqin Zhang, Huijuan Yang, Ping Zhang, Jihong Liu, Jianqing Zhu, Rong Yu Zang, null null
Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nature medicine (2024)
Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet E Feilotter, Hagen F Kennecke, Leylah Drusbosky, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Loree
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo- RAS -Wildtype Metastatic Colorectal Cancer Is Transient. JCO precision oncology 8 (2024)
Rong Jiang, Yanling Feng, Yulian Chen, Xi Cheng, Ting Yan Shi, Wen Gao, Huixun Jia, Shiyang Jiang, Yi Guo, Xiao Huang, Dongsheng Tu, Yuqin Zhang, Huijuan Yang, Ping Zhang, Jihong Liu, Jianqing Zhu, Rong Yu Zang, null null
Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nature medicine 30 (8) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus tissue tumor mutational burden as biomarkers of durvalumab plus tremelimumab response in patients with metastatic colorectal cancer in the CO.26 trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Joao Paulo Solar Vasconcelos, Nan Chen, Emma Titmuss, Dongsheng Tu, Stephanie Y Brule, Rachel Goodwin, Derek J Jonker, Timothy Jay Price, Zalcberg John, Malcolm J Moore, Christos S Karapetis, Lillian L Siu, Jeremy Shapiro, R John Simes, Sharlene Gill, Chris J O'Callaghan, Jonathan M Loree
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Arjun Gupta, Christopher J O'Callaghan, Liting Zhu, Derek J Jonker, Ralph P W Wong, Bruce Colwell, Malcolm J Moore, Christos S Karapetis, Niall C Tebbutt, Jeremy D Shapiro, Dongsheng Tu, Christopher M Booth
Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial. JCO oncology practice (2023)
Zhanfeng Wang, Wenmei Li, Hao Ding, Dongsheng Tu
A composite semiparametric homogeneity test for the distributions of multigroup interval-bounded longitudinal data. Journal of biopharmaceutical statistics (2023)
Yangqing Deng, Dongsheng Tu, Chris J O'Callaghan, Derek J Jonker, Christos S Karapetis, Jeremy Shapiro, Geoffrey Liu, Wei Xu
A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomes. Statistics in medicine (2023)
Zhanfeng Wang, Tao Li, Liqun Xiao, Dongsheng Tu
A threshold longitudinal Tobit quantile regression model for identification of treatment-sensitive subgroups based on interval-bounded longitudinal measurements and a continuous covariate. Statistics in medicine (2023)
Yangqing Deng, Dongsheng Tu, Chris J O'Callaghan, Geoffrey Liu, Wei Xu
Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributions. Statistical methods in medical research (2023)
Ian Gilron, Dongsheng Tu, Ronald R Holden, Dwight E Moulin, Scott Duggan, Roumen V Milev
Melatonin for Neuropathic Pain: Protocol for a Double-blind, Randomized Controlled Trial. JMIR research protocols 11 (9) (2022)
David Luke Thiessen, Yang Zhao, Dongsheng Tu
Unified estimation for Cox regression model with nonmonotone missing at random covariates. Statistics in medicine 41 (24) (2022)
Hagen F Kennecke, Chris J O'Callaghan, Jonathan M Loree, Hussein Moloo, Rebecca A C Auer, Derek J Jonker, Manoj J Raval, Reilly Musselman, Grace Ma, Antonio Caycedo-Marulanda, Vlad V Simianu, Sunil Patel, Lacey D Pitre, Ramzi Helewa, Vallerie L Gordon, Katerina Neumann, Halla Nimeiri, Max Sherry, Dongsheng Tu, Carl James Brown
Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
James T Topham, Chris J O'Callaghan, Harriet Feilotter, Hagen F Kennecke, Young S Lee, Weimin Li, Kimberly C Banks, Katie Quinn, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Loree
Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Kecheng Wei, Huichen Zhu, Guo-You Qin, Zhongyi Zhu, Dongsheng Tu
Multiply robust subgroup analysis based on a single-index threshold linear marginal model for longitudinal data with dropouts. Statistics in medicine 41 (15) (2022)
Karama Asleh, Dongsheng Tu, Dongxia Gao, Vivien Bramwell, Mark N Levine, Kathleen I Pritchard, Lois E Shepherd, Torsten O Nielsen
Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Shengqing Stan Gu, Stephanie Lheureux, Azin Sayad, Paulina Cybulska, Liat Hogen, Iryna Vyarvelska, Dongsheng Tu, Wendy R Parulekar, Matthew Nankivell, Sean Kehoe, Dennis S Chi, Douglas A Levine, Marcus Q Bernardini, Barry Rosen, Amit Oza, Myles A Brown, Benjamin G Neel
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening. Proceedings of the National Academy of Sciences of the United States of America 118 (25) (2021)
Yapeng Li, Xueying Zheng, Dongsheng Tu, James N Ingle, Paul E Goss, Wendy R Parulekar, Guoyou Qin
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R. Breast cancer research and treatment (2021)
Chunlin Wang, Dongsheng Tu
A bootstrap semiparametric homogeneity test for the distributions of multigroup proportional data, with applications to analysis of quality of life outcomes in clinical trials. Statistics in medicine 39 (12) (2020)
Lu Yang, Hui Song, Yingwei Peng, Dongsheng Tu
Joint analysis of longitudinal measurements and survival times with a cure fraction based on partly linear mixed and semiparametric cure models. Pharmaceutical statistics 20 (2) (2020)
Elisa Fontana, Gift Nyamundanda, David Cunningham, Dongsheng Tu, Maggie Chon U Cheang, Derek J Jonker, Lillian L Siu, Francesco Sclafani, Katherine Eason, Chanthirika Ragulan, Maria Antonietta Bali, Sanna Hulkki-Wilson, Jonathan M Loree, Paul M Waring, Mirella Giordano, Patrick Lawrence, Daniel Nava Rodrigues, Ruwaida Begum, Jeremy D Shapiro, Timothy J Price, Chiara Cremolini, Naureen Starling, Filippo Pietrantonio, Livio Trusolino, Christopher J O'Callaghan, Anguraj Sadanandam
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial. JCO precision oncology 4 (2020)
Xinyi Ge, Yingwei Peng, Dongsheng Tu
A threshold linear mixed model for identification of treatment-sensitive subsets in a clinical trial based on longitudinal outcomes and a continuous covariate. Statistical methods in medical research 29 (10) (2020)
Yang Lv, Guo-You Qin, Zhongyi Zhu, Dongsheng Tu
Quantile regression and empirical likelihood for the analysis of longitudinal data with monotone missing responses due to dropout, with applications to quality of life measurements from clinical trials. Statistics in medicine 38 (16) (2019)
Ye He, Huazhen Lin, Dongsheng Tu
A single-index threshold Cox proportional hazard model for identifying a treatment-sensitive subset based on multiple biomarkers. Statistics in medicine 37 (23) (2018)
Ian Gilron, Dongsheng Tu, Ronald R Holden, Alan C Jackson, Nader Ghasemlou, Scott Duggan, Elizabeth G VanDenKerkhof, Roumen V Milev
Pain Improvement With Novel Combination Analgesic Regimens (PAIN-CARE): Randomized Controlled Trial Protocol. JMIR research protocols 6 (6) (2017)
Ian Gilron, Dongsheng Tu, Ronald R Holden, Tanveer Towheed, Dan Ziegler, Louie Wang, Roumen V Milev, Christopher Gray
Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain. JMIR research protocols 6 (3) (2017)
Xueying Zheng, Guoyou Qin, Dongsheng Tu
A generalized partially linear mean-covariance regression model for longitudinal proportional data, with applications to the analysis of quality of life data from cancer clinical trials. Statistics in medicine 36 (12) (2017)
Ian Gilron, Dongsheng Tu, Ronald R Holden, Tanveer Towheed, Elizabeth G VanDenKerkhof, Roumen V Milev
Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid - Pregabalin Combination for the Treatment of Fibromyalgia Pain. JMIR research protocols 6 (8) (2017)